Compound Library

What a clinic actually needs to know before carrying it.

Operator-facing reference on the compounds a peptide program is usually built from — the category each sits in, which pharmacy path applies, and what carrying it means for your menu and your inventory. Not treatment information.

Recovery and tissue

BPC-157One of the most requested compounds in the category, and one of the most volatile in regulatory terms. Both facts matter when you decide whether it belongs on your menu.

TB-500Usually considered alongside BPC-157, and subject to the same regulatory movement — which means the same planning discipline.

Longevity and metabolic

NAD+Less regulatory turbulence than most of the category, and a delivery format that changes your room scheduling more than your inventory.

Growth hormone secretagogue

SermorelinCompoundable, but with a documentation and attestation burden that surprises clinics who plan for the medication and not for the process around it.

IpamorelinUsually positioned as part of a stack rather than a standalone offering, which changes how you package and price it.

CJC-1295The compound name covers more than one formulation, and treating them as interchangeable is a menu error clinics make early.

This library is written for clinic operators making menu, sourcing and inventory decisions. It is not medical advice, contains no dosing or protocol guidance, and makes no claim about the safety or effectiveness of any compounded preparation. Compounded medications are not FDA-approved. What any individual patient should receive is a decision for a licensed practitioner.

Your patients are already asking about peptides.Make sure your clinic is ready to answer.

Build and launch your peptide program with Revival RX Partners in 90 days.

Important

Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.